News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Sepehr Farahbakhshian, MS

Articles by Sepehr Farahbakhshian, MS

Comparison of Low-Dose Liraglutide Use Versus Other GLP-1 Receptor Agonists in Patients Without Type 2 Diabetes

ByEric T. Wittbrodt, PharmD, MPH,James M. Eudicone, MS, MBA,Sepehr Farahbakhshian, MS,Carrie McAdam-Marx, PhD, MSCI, RPh

April 14th 2018

Latest Updated Articles

Comparison of Low-Dose Liraglutide Use Versus Other GLP-1 Receptor Agonists in Patients Without Type 2 Diabetes
Published: April 14th 2018 | Updated:

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

5 Things to Know About the Oral GLP-1 Era

How Do GLP-1 Agonists Fit Into Stroke Care?

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

Exploring Identity, Appearance Experiences Among Patients With Alopecia

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text